ESLA

Estrella Immunopharma Inc.

Healthcare · Biotechnology

0.471$ -0.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ESLA
Line item	2020	2021	2022	2023	2024	2025
Revenue	0.00	0.00	0.00	0.00	–	0.00
Research & Development	0.01	0.04	0.30	0.11	0.17	0.28
Selling, General & Administrative	0.01	0.01	0.02	0.09	0.07	0.08
Total Operating Expenses	0.02	0.05	0.32	0.20	0.24	0.35
Operating Income	-0.02	-0.05	-0.32	-0.20	-0.24	-0.35
Pre-Tax Income	-0.02	-0.05	-0.32	-0.20	-0.24	-0.35
Income Tax Expense	-0.01	-0.01	0.00	–	0.00	0.00
Net Income	-0.02	-0.05	-0.32	-0.20	-0.24	-0.35
EBITDA	-0.02	-0.05	-0.32	–	-0.24	-0.35

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.